m+Medelevator.RU
← Поиск публикаций
Digital health · 2025

A pelvic health eRehabilitation program to address urogenital impairments after breast and gynecologic cancer: A proof-of-concept study protocol.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Bernard Stéphanie, Perreault Kadija, Pepin Donna, Gauthier Lynn R, Roy-Richard Chloé, Lamontagne Marie-Ève, Dalzell Mary-Ann, Mcneely Margaret L

Аннотация

BACKGROUND: Incontinence and vulvar pain are common urogenital dysfunctions after breast and gynecological cancers (BGCs). Recent evidence suggests that pelvic health physiotherapy can improve these dysfunctions and enhance quality of survivorship, but several barriers limit access to such care. Virtual programs are proposed as a strategy to improve access.

AIM: The main aim of this proof-of-concept study is to evaluate the feasibility and acceptability of the newly designed Pelvic Health eRehabilitation Program in people treated for BGCs. The study also aims to explore the preliminary effectiveness of the Program in reducing urogenital impairments.

METHODS: This study uses a proof-of-concept, interventional prospective cohort design. Twenty individuals with BGCs presenting with urogenital dysfunction (score ≥2 on the Pelvic Floor Bother Questionnaire) will be recruited in the Canadian provinces of Quebec and Alberta. The Program includes twelve weekly small-group online educational sessions with a pelvic health physiotherapist, five individual exercise prescription sessions, and access to a variety of online resources. The following standardized patient-reported outcome measures will be used: the International Consultation on Incontinence modular questionnaires for bladder and bowel symptoms, the Vulvar Pain Assessment Questionnaire, and the Female Sexual Function Index. Evaluations will be conducted before (E1), halfway through (E2), and immediately after (E3) the intervention.

CONCLUSION: Findings from this study will inform the feasibility, acceptability, and preliminary effectiveness of the Program for individuals experiencing urogenital dysfunction following BGCs treatment, supporting future development of a randomized controlled trial. This virtual Program holds promise to improve equity in access to pelvic health services.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты